MedPath

The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis

Phase 1
Conditions
Atrophic Vaginitis
Interventions
Drug: Chinese Herbal Compound Ointment
Registration Number
NCT02733731
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Brief Summary

Objective:To evaluate the effect and safety of the traditional chinese medicine oil agent on senile atrophic compared as compared to estriol cream in aged woman.

Design: A randomized double-blind controlled trial.

Setting: The hospital ward.

Participants: 200 postmenopausal woman with senile vaginitis (mean age 56).

Intervention: The traditional chinese medicine oil and estriol cream were separately intravaginal administrated in treatment group and control group for 3 weeks,follow-up 1 month.

Measurement: symptom improving(pain and itch) and onset time, edema-size of vaginal wall, vaginal discharge, and PH changes.

Detailed Description

80 postmenopausal women living in the communities near the hospital with AV (atrophic vaginitis) symptoms were recruited for this clinical trial. Patients with AV receiving external treatment and requiring hospitalization were randomized in a double-blind, single-centre trial. Subjects received CHCO (Chinese Herbal Compound Ointment) topical vaginal application in experimental group, while estriol in control group. The dosage of medicine for single treatment once a day in two group is 0.5g.The total time for therapy is 3 weeks in two groups. Assessment indicators:vagine PH, sIgA and IL-1βchanges, the degree of symptoms improving, onset time, edema-size of vaginal wall, vaginal discharge, and relapses and retreatment effect.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Postmenopausal women
  • With typical clinical manifestations: virginal genital itching or burning sense, Increased vaginal secretions, a yellow, a serious bloody pus-like leucorrhea, or sexual intercourse pain
  • Gynecological examination: Vaginal epithelium atrophy,Vaginal folds flat or disappear, mucosal hyperemia, superficial ulceration
  • Both ALT and AST are normal or less than 2 times, bilirubin is normal
  • Serum creatinine level is within the normal range
  • ECG is normal;
Exclusion Criteria
  • Gynecological and breast Oncology, endometrial hyperplasia(≥5mm)
  • Estrogenic drugs or probiotics used in four week
  • Participate in other clinical trials;Thrombotic diseases
  • Abnormal vaginal bleeding without clear diagnose
  • Estriol allergy
  • Severe pneumonia, tuberculosis, lung abscess, myocarditis
  • heart,liver or kidney failure(NYHA class III-IV,ALT to AST ratio twice more than upper limit of normal
  • sexually transmitted diseases;mental disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Chinese Herbal Compound OintmentChinese Herbal Compound OintmentThis kind of CHCO composed of several chinese herbs,dong quai,angelica,resina draconis and lithospermum.The dosage of medicine for single treatment once a day in two group is 0.5g,The total time for therapy is 3 weeks.
EstriolEstriolThe dosage of medicine for single treatment once a day in two group is 0.5g,The total time for therapy is 3 weeks in two groups.
Primary Outcome Measures
NameTimeMethod
symptom questionnaire scores77days
sign questionnaire scores77days
Secondary Outcome Measures
NameTimeMethod
recurrence rate retreatment effectWithin 28days after treatment
retreatment effective rateWithin 56days after treatment
PH value of vaginae secretion49days
sIgA value of vaginae secretion49days
IL-1βvalue of vaginae secretion49days

Trial Locations

Locations (1)

The First Affiliated Hospital of Sun-yat Sen University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath